Dyrk4 Antibodies

Santa Cruz Biotechnology delivers a wide array of Dyrk4 monoclonal antibodies for research focused on dual-specificity tyrosine phosphorylation-regulated kinase 4 (Dyrk4). Dyrk4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dyrk4 is a member of the DYRK family of kinases, which play essential roles in cell proliferation, differentiation, and apoptosis. Dyrk4 participates in various signaling pathways and maintains proper neuronal function and development. Research has shown that Dyrk4 may contribute to the progression of neurodegenerative disorders and cancer. Investigating Dyrk4's cellular mechanisms can provide valuable insights into potential therapeutic strategies. Understanding Dyrk4's role in disease pathways could lead to new treatment approaches. Dyrk4 Antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of Dyrk4's biological significance and therapeutic potential.